Literature DB >> 17605962

Metabolic syndrome and chronic kidney disease in a Chinese population aged 40 years and older.

LuXia Zhang1, Li Zuo, Fang Wang, Mei Wang, ShuYu Wang, LiSheng Liu, HaiYan Wang.   

Abstract

OBJECTIVE: To explore the relationship between metabolic syndrome and chronic kidney disease (CKD) in a study population from a developing country. PARTICIPANTS AND METHODS: The prevalence of metabolic syndrome (as most recently defined by the International Diabetes Federation) and CKD (defined as an estimated glomerular filtration rate of < 60 mL/min per 1.73 m2 and/or albuminuria) was determined in 2310 study participants (age > or =40 years) from Beijing, China, between May 12 and December 7, 2004. The relationship between metabolic syndrome and CKD was then analyzed.
RESULTS: Participants with metabolic syndrome had a higher prevalence of CKD (15.4% vs 8.3%; P<.001) than those without the syndrome. As the number of metabolic syndrome traits increased, so did the prevalence of CKD. Strong unadjusted and adjusted associations were observed between metabolic syndrome and CKD. For participants without hypertension and diabetes, metabolic syndrome was also associated with CKD (odds ratio, 2.03; 95% confidence interval, 1.05-3.94).
CONCLUSIONS: In these 2310 Chinese study participants aged 40 years and older, metabolic syndrome was associated with CKD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17605962     DOI: 10.4065/82.7.822

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  16 in total

1.  Gender-specific association between metabolic syndrome and decreased glomerular filtration rate in elderly population.

Authors:  Jia Wen; Chen-Xian Guo; Ming-Gen Lu; Yao Lu; Yun Huang; Xing Liu; Ying Li; Zhi-Jun Huang; Ya-Ping Zhang; Hong Yuan
Journal:  Int Urol Nephrol       Date:  2016-01-02       Impact factor: 2.370

2.  Report of the Asian Forum of Chronic Kidney Disease Initiative (AFCKDI) 2007. "Current status and perspective of CKD in Asia": diversity and specificity among Asian countries.

Authors:  Yusuke Tsukamoto; HaiYan Wang; Gavin Becker; Hung-Chun Chen; Dae-Suk Han; David Harris; Enyu Imai; Vivekanand Jha; Philip K T Li; Evan J C Lee; Seiichi Matsuo; Yasuhiko Tomino; Kriang Tungsanga; Kunihiro Yamagata; Akira Hishida
Journal:  Clin Exp Nephrol       Date:  2009-03-14       Impact factor: 2.801

3.  Metabolic syndrome and renal injury.

Authors:  Yi-Jing Sheen; Wayne Huey-Herng Sheu
Journal:  Cardiol Res Pract       Date:  2011-03-13       Impact factor: 1.866

4.  Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad.

Authors:  Mário Raimundo; José António Lopes
Journal:  Cardiol Res Pract       Date:  2011-02-20       Impact factor: 1.866

5.  Metabolic syndrome and its components associated with chronic kidney disease.

Authors:  Ali Maleki; Mahdi Montazeri; Negin Rashidi; Mohammad Montazeri; Elham Yousefi-Abdolmaleki
Journal:  J Res Med Sci       Date:  2015-05       Impact factor: 1.852

6.  Association between metabolic syndrome and chronic kidney disease in perimenopausal women.

Authors:  Yongqiang Li; Liqin Zhao; Youming Chen; Aiqun Liu; Xinyu Liu; Xiaofei Shao; Ying Zhang; Honglei Wang; Xiaohong Wang; Bin Li; Kangping Deng; Qin Liu; Harry Holthöfer; Hequn Zou
Journal:  Int J Environ Res Public Health       Date:  2013-08-30       Impact factor: 3.390

7.  Interaction Effects of the Leu162Val PPAR α and Pro12Ala PPAR γ 2 Gene Variants with Renal Function in Metabolic Syndrome Population.

Authors:  Sarraj Mohamed Youssef; Najah Mohamed; Slimani Afef; Ben Hamda Khaldoun; Neffati Fadoua; Najjar Mohamed Fadhel; Slimane Mohamed Naceur
Journal:  PPAR Res       Date:  2013-04-04       Impact factor: 4.964

8.  Metabolic syndrome, C-reactive protein and microalbuminuria in a rural Chinese population: a cross-sectional study.

Authors:  Liping Jiang; Wen Huang; Yuanbo Liang; Fenghua Wang; Xinrong Duan; Xiaohui Yang; Jiangping Wen; Ningli Wang
Journal:  BMC Nephrol       Date:  2013-06-02       Impact factor: 2.388

9.  Metabolic syndrome, C-reactive protein, and mortality in U.S. Blacks and Whites: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.

Authors:  Takeki Suzuki; Jenifer Voeks; Neil A Zakai; Nancy Swords Jenny; Todd M Brown; Monika M Safford; Martin LeWinter; George Howard; Mary Cushman
Journal:  Diabetes Care       Date:  2014-05-30       Impact factor: 19.112

10.  Metabolic syndrome and other cardiovascular risk factors associated with the progression of IgA nephropathy.

Authors:  Tibor Kovács; Tibor Vas; Csaba P Kovesdy; István Késõi; Balázs Sági; István Wittmann; Judit Nagy
Journal:  Clin Kidney J       Date:  2012-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.